23rd -24th September 2021

MarketsandMarkets Advanced Genetic Sequencing Virtual Conference [Time zone- Eastern Standard Time (EST)]

Nanopore sequencing and its application to pandemic epidemiological survey of SARS CoV-19 and strains surveillance. Now, with COVID therapeutic manufacturing taking priority, there is a big desire to accelerate other clinical pipeline because of ample opportunity for new medicine.

MarketsandMarkets is proud to announce the Advanced Genetic Sequencing Virtual Conference scheduled to be held on 23-24 September 2021 will hold discussions on trending technologies and its applications, challenges of implying these technologies into clinical specimen, practice of sequencing in healthcare domain specifically to cancer cells, overview of the data used in these technologies and its applications. This event will witness an overwhelming participation of leading healthcare and industry decision makers.

MarketsandMarkets is proud to announce the Advanced Genetic Sequencing Virtual Conference scheduled to be held on 23-24 September presents to you a virtual platform to keep your scientific exchange live. It will hold discussions on trending technologies of sequencing and its applications, challenges of implying these technologies into clinical specimen, practice of sequencing in healthcare domain specifically to cancer cells, overview of the data used in these technologies and its applications. This event will witness an overwhelming participation of leading healthcare and industry decision makers.

WHAT TO EXPECT
Key Highlights
  • Short Read Sequencing & Long Read Sequencing – Single cell Analysis 
  • Human disease – Virus interacts with DNA and how sequencing helps in it. 
  • Spatial sequencing and its applications 
  • What’s new in Nano pore sequencing technology. Applications of Nano pore sequencing in healthcare 
  • Nano pore sequencing to pandemic epidemiology survey of Covid-19 and strain surveillance 
  • A multipanel IS and its uses in IHC
Why Attend?
  • Learn about the recent trends and advancements occurring in Sequencing market.
  • Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical manufactures, therapeutic companies and Healthcare who will address most critical challenges in different sequencing process.
  • Opportunity to network and exchange scientific knowledge with expert speakers from leading manufacturers, global regulators, and solution providers

 

Who Should Attend?

Professionals in Healthcare, Therapeutics, Universities/ Pharmaceuticals:

  • C-Level
  • Vice Presidents
  • Presidents
  • Senior Directors
  • Directors
  • Global Heads
  • Heads
  • Managers

Working in departments of Bioinformatics, Genomics, Molecular Biology, Oncology, Biotechnology and Biochemistry

CONFERENCE AGENDA
CONFERENCE SPEAKERS
Advisors
Matt Davis

Matt Davis

Director, Molecular biology and Sequencing
Gritstone Oncology, Inc.

Matt Davis

Director, Molecular biology and Sequencing
Gritstone Oncology, Inc.
Speakers
Dr. Catia Moutinho

Dr. Catia Moutinho

Group Leader Single Cell Technology Development
GWCCG, Australia

Dr. Catia Moutinho

Group Leader Single Cell Technology Development
GWCCG, Australia
Wei Vivian

Wei Vivian

Assistant Professor
Rutgers School of Public Health

Wei Vivian

Assistant Professor
Rutgers School of Public Health
Ning Wang

Ning Wang

Bioinformatics Lead
Arcus Biosciences

Ning Wang

Bioinformatics Lead
Arcus Biosciences
Grace Zhao

Grace Zhao

Co- Founder
Avida Biomed

Grace Zhao

Co- Founder
Avida Biomed
Bhagya Wijayawardena

Bhagya Wijayawardena

Global Commercial Product Manager
Beckman Coulter

Bhagya Wijayawardena

Global Commercial Product Manager
Beckman Coulter
Shrikant Mane

Shrikant Mane

Executive Director
Yale Center for Genome Analysis (YCGA)

Shrikant Mane

Executive Director
Yale Center for Genome Analysis (YCGA)
Seth Crosby

Seth Crosby

Director, Research Collaborations
Washington University School of Medicine

Seth Crosby

Director, Research Collaborations
Washington University School of Medicine
Matt Davis

Matt Davis

Director, Molecular biology and Sequencing
Gritstone Oncology, Inc.

Matt Davis

Director, Molecular biology and Sequencing
Gritstone Oncology, Inc.
SPONSORS
Platinium
example-image

Beckman Coulter

PARTNERS
Media Partners
example-image

PharmaTutor

example-image

Pharma Journalist

example-image

This Week in Digital Health

PAST EVENT GALLERY